We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company is currently holding clinical trials of its i-Factor Peptide Enhanced Bone Graft product for transforaminal lumbar interbody fusion surgery. Read More
“Following recent market developments, we have made the strategic business decision to exit from [notified body certification] services,” said Lloyd’s Register Quality Assurance. Read More